Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA.
Gastrointest Endosc. 2014 Aug;80(2):299-306. doi: 10.1016/j.gie.2014.02.1029. Epub 2014 May 3.
The United Kingdom (U.K.) post-adenoma resection guidelines recommend earlier surveillance for patients with 5 or more adenomas or 3 to 4 adenomas of which one is 10 mm or larger compared with U.S. guidelines.
To evaluate the effect of using the U.K. guideline on a U.S. cohort of adenoma patients.
Single-center, retrospective study.
Indiana University Hospital and an associated ambulatory surgery center.
A total of 1414 patients with baseline adenoma findings belonging to one of 5 risk categories and with a follow-up colonoscopy more than 200 days later.
Colonoscopy, polypectomy.
Incidence of advanced lesions at follow-up colonoscopy.
Advanced neoplasms at follow-up occurred in 16.3% of patients with 5 or more adenomas including 1 that was 10 mm or larger, 8.6% of patients with 3 or 4 adenomas including 1 that was 10 mm or larger, 5% of those with 5 or more adenomas all smaller than 10 mm, 1.8% of those with 3 or 4 adenomas all smaller than 10 mm, and 1.4% of those with 1 to 2 adenomas smaller than 10 mm. Logistic regression analyses showed that the rate of advanced lesions at first follow-up was increased in persons with 3 or more baseline adenomas and at least 1 that is 10 mm or larger compared with those with 1 to 4 small baseline adenomas.
Single-center, retrospective study.
Our results indicate the U.K. guideline predicts higher risk groups for advanced neoplasia at first follow-up. Our study had inadequate power to show better prediction of incident cancer. Additional study of other databases is warranted.
与美国指南相比,英国(U.K.)腺瘤切除术后指南建议对有 5 个或更多腺瘤或 3 至 4 个腺瘤且其中 1 个为 10mm 或更大的患者进行更早的监测。
评估在 U.S. 腺瘤患者队列中使用英国指南的效果。
单中心、回顾性研究。
印第安纳大学医院和相关的门诊手术中心。
共有 1414 名基线腺瘤患者,属于 5 个风险类别之一,并且在 200 天以上后进行了随访结肠镜检查。
结肠镜检查、息肉切除术。
随访结肠镜检查中高级别病变的发生率。
在有 5 个或更多包括 1 个 10mm 或更大的腺瘤、3 或 4 个包括 1 个 10mm 或更大的腺瘤的患者中,随访时发生高级别肿瘤的比例分别为 16.3%、8.6%,5 个或更多腺瘤全部小于 10mm 的患者为 5%,3 或 4 个腺瘤全部小于 10mm 的患者为 1.8%,1 至 2 个腺瘤全部小于 10mm 的患者为 1.4%。Logistic 回归分析显示,与 1 至 4 个小基线腺瘤相比,基线有 3 个或更多且至少 1 个为 10mm 或更大的腺瘤的患者首次随访时高级别病变的发生率增加。
单中心、回顾性研究。
我们的结果表明,英国指南预测首次随访时高级别肿瘤的风险较高。我们的研究没有足够的能力来显示对癌症发病的更好预测。需要对其他数据库进行进一步研究。